Results 271 to 280 of about 1,512,475 (325)

Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada

Autoimmunity
For some of the COVID-19 vaccines, the drug substances released to market were manufactured differently than those used in clinical trials. Manufacturing nucleoside-modified mRNA (modRNA) for commercial COVID-19 vaccines relies on RNA polymerase ...
D. Speicher, Jessica Rose, Kevin McKernan   +2 more
semanticscholar   +1 more source

RETRACTED ARTICLE: Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19

npj Vaccines
This review examines Moderna’s mRNA-1083 and Pfizer/BioNTech’s mRNA-1020/1030 dual-target vaccines for COVID-19 and influenza. Both utilize mRNA technology, demonstrating strong immunogenicity and favorable safety profiles.
A. Akingbola, A. Adegbesan, Kolade Adegoke, Courage Idahor, P. Mariaria, Favour Peters, Raolat Adenike Salami, Olajide Ojo, Emmanuel Nwaeze, Owolabi Abdullahi, Joel Chuku   +10 more
semanticscholar   +1 more source

COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

European Review for Medical and Pharmacological Sciences, 2021
S. Meo, I. Bukhari, J. Akram, A. Meo, D. Klonoff   +4 more
semanticscholar   +1 more source

Informatica moderna

2018
Questo libro presenta i concetti fondamentali dell’informatica e dei sistemi informativi aggiornati agli sviluppi attuali fino a giungere alla Pubblica Amministrazione Digitale. Nasce da una esperienza lavorativa inerente la progettazione, lo sviluppo e la gestione di sistemi informativi e da esperienze di docenza in corsi universitari e professionali;
openaire   +1 more source

Moderna

New Scientist, 2021
openaire   +1 more source

Moderna

2015
Problemski članak o odnosu Antuna Gustava Matoša i pokreta hrvatske ...
openaire   +1 more source